Baxter's profits grow on BioScience performance
This article was originally published in Scrip
Executive Summary
Baxterended 2008 strongly with its BioScience business driving a 19% increase in its fourth-quarter net income. Profits reached $569 million for the period as sales by the firm's BioScience arm grew by 12% to $1.4 billion.